Advertisement

Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management

      Abstract

      There is increasing awareness that impulse control disorders (ICDs), including pathological gambling, hyper-sexuality, compulsive eating and buying, can occur as a complication of Parkinson's disease (PD). In addition, other impulsive or compulsive disorders have been reported to occur, including dopamine dysregulation syndrome (DDS) and punding. Case reports and prospective studies have reported an association between ICDs and the use of dopamine receptor agonists at higher doses, and DDS has been associated with l-dopa at higher doses or short-acting dopamine receptor agonists. Risk factors for ICDs include male sex, younger age or younger age at PD onset, a pre-PD history of ICD symptoms, history of substance use or bipolar disorder, and a personality profile characterized by impulsiveness. The management of clinically significant ICD symptoms should consist of modifications to dopamine replacement therapy, particularly dopamine receptor agonists, which is usually associated with an improvement of ICDs. There is no empirical evidence supporting the use of psychiatric drugs for ICDs in PD. Functional neuroimaging studies such as functional MRI and PET can investigate in vivo the neurobiological basis of these pathological behaviours.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Parkinsonism & Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American Psychiatric Association
        Diagnostic and statistical manual of mental disorders, fourth edition, text revision. American Psychiatric Association, Washington, DC2000
        • Evans AH
        • Katzenschlager R
        • Paviour D
        • O'Sullivan JD
        • Appel S
        • Lawrence AD
        • et al.
        Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome.
        Mov Disord. 2004; 19: 397-405
        • Weintraub D
        Dopamine and impulse control disorders in Parkinson's disease.
        Ann Neurol. 2008; 64: S93-100
        • Giovannoni G
        • O'Sullivan JD
        • Turner K
        • Manson AJ
        • Lees AJ
        Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies.
        J Neurol Neurosurg Psychiatry. 2000; 68: 423-428
        • Holden C
        “Behavioral” addictions: do they exist?.
        Science. 2001; 294: 980-982
        • Tamminga CA
        • Nestler EJ
        Pathological gambling: focusing on the addiction, not the activity.
        Am J Psychiatry. 2006; 163: 180-181
        • Brewer JA
        • Potenza MN
        The neurobiology and genetics of impulse control disorders: relationships to drug addictions.
        Biochem Pharmacol. 2008; 75: 63-75
        • Hollander E
        • Allen A
        Is compulsive buying a real disorder, and is it really compulsive?.
        Am J Psychiatry. 2006; 163: 1670-1672
        • Driver-Dunckley E
        • Samanta J
        • Stacy M
        Pathological gambling associated with dopamine agonist therapy in Parkinson's disease.
        Neurology. 2003; 61: 422-423
        • Lu C
        • Bharmal A
        • Suchowersky O
        Gambling and Parkinson disease.
        Arch Neurol. 2006; 63: 298
        • Grosset KA
        • Macphee G
        • Pal G
        • Stewart D
        • Watt A
        • Davie J
        • et al.
        Problematic gambling on dopamine agonists: not such a rarity.
        Mov Disord. 2006; 21: 2206-2208
        • Voon V
        • Hassan K
        • Zurowski M
        • Duff-Canning S
        • de Souza M
        • Fox S
        • et al.
        Prospective prevalence of pathological gambling and medication association in Parkinson disease.
        Neurology. 2006; 66: 1750-1752
        • Weintraub D
        • Siderowf AD
        • Potenza MN
        • Goveas J
        • Morales KH
        • Duda JE
        • et al.
        Association of dopamine agonist use with impulse control disorders in Parkinson disease.
        Arch Neurol. 2006; 63: 969-973
        • Voon V
        • Hassan K
        • Zurowski M
        • de Souza M
        • Thomsen T
        • Fox S
        • et al.
        Prevalence of repetitive and reward-seeking behaviors in Parkinson disease.
        Neurology. 2006; 67: 1254-1257
        • Isaias IU
        • Siri C
        • Cilia R
        • De Gaspari D
        • Pezzoli G
        • Antonini A
        The relationship between impulsivity and impulse control disorders in Parkinson's disease.
        Mov Disord. 2008; 23: 411-415
        • Christenson GA
        • Faber RJ
        • deZwaan M
        • Raymond NC
        • Specker SM
        • Ekern MD
        • et al.
        Compulsive buying: descriptive characteristics and psychiatric comorbidity.
        J Clin Psychiatry. 1994; 55: 5-11
        • Crockford D
        • Quickfall J
        • Currie S
        • Furtado S
        • Suchowersky O
        • El-Guebaly N
        Prevalence of problem and pathological gambling in Parkinson's disease.
        J Gambl Stud. 2008; 24: 411-422
        • Avanzi M
        • Baratti M
        • Cabrini S
        • Uber E
        • Brighetti G
        • Bonfà F
        Prevalence of pathological gambling in patients with Parkinson's disease.
        Mov Disord. 2006; 21: 2068-2072
        • Ceravolo R
        • Frosini D
        • Rossi C
        • Nicoletti V
        • Berti C
        • Unti E
        • et al.
        Prevalence of impulse control disorders in Parkinson's disease.
        Neurol Sci. 2009; 30: 456
        • Vogel HP
        • Shiffter R
        Hypersexuality–a complication of dopaminergic therapy in Parkinson's disease.
        Pharmacopsychiatria. 1983; 16: 107-110
        • Harvey NS
        Serial cognitive profiles in levodopa-induced hypersexuality.
        Br J Psychiatry. 1988; 153: 833-836
        • Uitti RJ
        • Tanner CM
        • Rajput AH
        • Goetz CG
        • Klawans HL
        • Thiessen B
        Hypersexuality with antiparkinsonian therapy.
        Clin Neuropharmacol. 1989; 12: 375-383
        • O'Sullivan JD
        • Hughes AJ
        Apomorphine-induced penile erections in Parkinson's disease.
        Mov Disord. 1998; 13: 536-539
        • Klos KJ
        • Bower JH
        • Josephs KA
        • Matsumoto JY
        • Ahlskog JE
        Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy.
        Parkinsonism Relat Disord. 2005; 11: 381-386
        • Gallagher DA
        • O'Sullivan SS
        • Evans AH
        • Lees AJ
        • Schrag A
        Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series.
        Mov Disord. 2007; 22: 1757-1763
        • Evans AH
        • Lawrence AD
        • Potts J
        • Appel S
        • Lees AJ
        Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease.
        Neurology. 2005; 65: 1570-1574
        • Giladi N
        • Weitzman N
        • Schreiber S
        • Shabtai H
        • Peretz C
        New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset.
        J Psychopharmacol. 2007; 21: 501-506
        • Singh A
        • Kandimala G
        • Dewey Jr, RB
        • O'Suilleabhain P
        Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists.
        J Clin Neurosci. 2007; 14: 1178-1181
        • Voon V
        • Thomsen T
        • Miyasaki JM
        • deSouza M
        • Shafro A
        • Fox SH
        • et al.
        Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease.
        Arch Neurol. 2007; 64: 212-216
        • Pontone G
        • Williams JR
        • Bassett SS
        • Marsh L
        Clinical features associated with impulse control disorders in Parkinson disease.
        Neurology. 2006; 67: 1258-1261
        • Santangelo G
        • Vitale C
        • Trojano L
        • Verde F
        • Grossi D
        • Barone P
        Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease.
        Mov Disord. 2009; 24: 899-905
        • Dodd ML
        • Klos KJ
        • Bower JH
        • Geda YE
        • Josephs KA
        • Ahlskog JE
        Pathological gambling caused by drugs used to treat Parkinson disease.
        Arch Neurol. 2005; 62: 1377-1381
        • Driver-Dunckley ED
        • Noble BN
        • Hentz JG
        • Evidente VG
        • Caviness JN
        • Parish J
        • et al.
        Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome.
        Clin Neuropharmacol. 2007; 30: 249-255
        • Blum K
        • Sheridan PJ
        • Wood RC
        • Braverman ER
        • Chen TJ
        • Comings DE
        Dopamine D2 receptor gene variants: association and linkage studies in impulsiveaddictive-compulsive behaviour.
        Pharmacogenetics. 1995; 5: 121-141
        • Comings DE
        • Gonzalez N
        • Wu S
        • Gade R
        • Muhleman D
        • Saucier G
        • et al.
        Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse.
        Am J Med Genet. 1999; 88: 358-368
        • Pérez de Castro I
        • Ibáñez A
        • Torres P
        • Sáiz-Ruiz J
        • Fernández-Piqueras J
        Genetic association study between pathological gambling and a functional DNA polymorphism at the D4 receptor gene.
        Pharmacogenetics. 1997; 7: 345-348
        • Lee JY
        • Lee EK
        • Park SS
        • Lim JY
        • Kim HJ
        • Kim JS
        • et al.
        Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease.
        Mov Disord. 2009 Jun 26; ([Epub ahead of print])
        • Reuter J
        • Raedler T
        • Rose M
        • Hand I
        • Gläscher J
        • Büchel C
        Pathological gambling is linked to reduced activation of the mesolimbic reward system.
        Nat Neurosci. 2005; 8: 147-148
        • Evans AH
        • Pavese N
        • Lawrence AD
        • Tai YF
        • Appel S
        • Doder M
        • et al.
        Compulsive drug use linked to sensitized ventral striatal dopamine transmission.
        Ann Neurol. 2006; 59: 852-858
        • Cilia R
        • Siri C
        • Marotta G
        • Isaias IU
        • De Gaspari D
        • Canesi M
        • et al.
        Functional abnormalities underlying pathological gambling in Parkinson disease.
        Arch Neurol. 2008; 65: 1604-1611
        • Steeves TD
        • Miyasaki J
        • Zurowski M
        • Lang AE
        • Pellecchia G
        • Van Eimeren T
        • et al.
        Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study.
        Brain. 2009; 132: 1376-1385
        • Mamikonyan E
        • Siderowf AD
        • Duda JE
        • Potenza MN
        • Horn S
        • Stern MB
        • et al.
        Long-term follow-up of impulse control disorders in Parkinson's disease.
        Mov Disord. 2008; 23: 75-80
        • Ardouin C
        • Voon V
        • Worbe Y
        • Abouazar N
        • Czernecki V
        • Hosseini H
        • et al.
        Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation.
        Mov Disord. 2006; 21: 1941-1946
        • Kurlan R
        Disabling repetitive behaviors in Parkinson's disease.
        Mov Disord. 2004; 19: 433-437
        • Courty E
        • Durif F
        • Zenut M
        • Courty P
        • Lavarenne J
        Psychiatric and sexual disorders induced by apomorphine in Parkinson's disease.
        Clin Neuropharmacol. 1997; 20: 140-147
        • Jiménez-Jiménez FJ
        • Sayed Y
        • García-Soldevilla MA
        • Barcenilla B
        Possible zoophilia associated with dopaminergic therapy in Parkinson disease.
        Ann Pharmacother. 2002; 36: 1178-1179
        • Gschwandtner U
        • Aston J
        • Renaud S
        • Fuhr P
        Pathologic gambling in patients with Parkinson's disease.
        Clin Neuropharmacol. 2001; 24: 170-172
        • Grant JE
        • Potenza MN
        Impulse control disorders: clinical characteristics and pharmacological management.
        Ann Clin Psychiatry. 2004; 16: 27-34
        • Klos KJ
        • Bower JH
        • Josephs KA
        • Matsumoto JY
        • Ahlskog JE
        Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy.
        Parkinsonism Relat Disord. 2005; 11: 381-386
        • Grant JE
        • Potenza MN
        • Hollander E
        • Cunningham-Williams R
        • Nurminen T
        • Smits G
        • et al.
        Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.
        Am J Psychiatry. 2006; 163: 303-312